surmount-4 tirzepatide withdrawal weight regain

surmount-4 tirzepatide withdrawal weight regain after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide withdrawal leads to 25%

Name: surmount-4 tirzepatide withdrawal weight regain after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide withdrawal leads to 25%
Brand: aeroscroll.com
SKU: 6507469748
Price: 25.77 USD
Availability: InStock
Rating: 4.1602 (26 reviews)

SKU: 6507469748

4.2

USD25.77 USD48.77

Pay in 4 interest-free payments of $6.44 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

The SURMOUNT-4 trial found that patients who continued tirzepatide 15 mg lost an additional 5.5% of body weight over 52 weeks, while those switched to placebo regained approximately 14.0% (Aronne et al., JAMA 2024)

Personalized GLP-1 targets one pathway (GLP-1) that supports appetite regulation and metabolic health

Mol Ther Methods Clin Dev

If you take semaglutide in another form, such as semaglutide tablets, side effects may differ and you should check your patient information leaflet for further information

Exchange/Return Notes